Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-22-001185
Filing Date
2022-02-22
Accepted
2022-02-22 13:07:24
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3332
  Complete submission text file 0001683168-22-001185.txt   4927
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Issuer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 579 RUE LAJEUNESSE LAVAL A8 H7X 3K4
Business Address
Slilaty Steve N. (Reporting) CIK: 0001474684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41282 | Film No.: 22657001